Historical record - last NADAC effective date: 2/19/2014
Product Information
MORPHINE SULFATE ER 50 MG CAP is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $6.6583 per EA under NDC 00832022850. Its NADAC has been published 15 times since Nov 28, 2013.
FDA first approved this application on Jun 3, 2013.
Strength
50 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832022850
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
2/19/2014
Active Ingredients
MORPHINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA202104FDA Approved
6/3/2013
On Market Since
6/30/2013
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE SULFATE ER 50 MG CAP has been published 15 times since Nov 28, 2013, and over the history we have for it it has risen 3.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.6583 per EA |
|---|---|
| All-time high | $6.8272 (Feb 12, 2014) |
| All-time low | $6.4517 (Nov 28, 2013) |
| Median price | $6.6284 |
| Average price | $6.6520 |
| Largest weekly change | +3.0% (Jan 22, 2014) |
| Weeks tracked | 15 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+3.2%
Last surveyed Mar 5, 2014 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 49% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Morphine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MORPHINE SULFATE ER 50 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULFATE ER 50 MG CAP, manufactured by Upsher-Smith Laboratories LLC, is $6.6583 per EA (NDC 00832022850), effective Mar 5, 2014.
How has the price of MORPHINE SULFATE ER 50 MG CAP changed over time?
Over the history we have for it, the NADAC for MORPHINE SULFATE ER 50 MG CAP has risen 3.2%. It has been tracked across 15 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MORPHINE SULFATE ER 50 MG CAP?
Since Nov 28, 2013, the NADAC for MORPHINE SULFATE ER 50 MG CAP has ranged from a low of $6.4517 (Nov 28, 2013) to a high of $6.8272 (Feb 12, 2014), with a median of $6.6284 per EA.
Are there cheaper alternatives to MORPHINE SULFATE ER 50 MG CAP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MORPHINE SULFATE ER 50 MG CAP, is $3.4065 per EA — about 49% below MORPHINE SULFATE ER 50 MG CAP.
Who manufactures MORPHINE SULFATE ER 50 MG CAP?
MORPHINE SULFATE ER 50 MG CAP (NDC 00832022850) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.